During the past decade, Urologicka klinika 1.LF UK a VFN conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Urologicka klinika 1.LF UK a VFN" are "Castration-Resistant Prostatic Cancer" (1 trials), "Metastatic Castrate Sensitive Prostate Cancer" (1 trials) and "Prostatic Neoplasms" (1 trials). Many other conditions were trialed in "Urologicka klinika 1.LF UK a VFN" in a lesser frequency.

Most popular intervention types in "Urologicka klinika 1.LF UK a VFN" are "Drug" (3 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Niraparib" (2 trials), "Prednisone" (2 trials), "Abiraterone Acetate" (1 trials), "Abiraterone acetate (AA)" (1 trials) and "Apalutamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Urologicka klinika 1.LF UK a VFN" are 3 trials for "Male" genders.

Currently, there are NaN active trials in "Urologicka klinika 1.LF UK a VFN". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Urologicka klinika 1.LF UK a VFN, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Urologicka klinika 1.LF UK a VFN, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".